Goldpoint Clinical Research, LLC — Indianapolis, Indiana

Goldpoint Clinical Research, LLC is a clinical research site located in Indianapolis, Indiana, United States 46260.

Crixeo Health Trust Score: 80/100 (GOOD). This profile has not yet been claimed by the site owner.

Goldpoint Clinical Research, LLC has participated in 19 clinical trials.

Therapeutic areas: Binge Eating Disorder, Smoking Cessation, ADHD.

Sponsors: Shire, Pfizer, Eli Lilly and Company.

Sponsor Feasibility Report

Trust Score: 80/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Goldpoint Clinical Research, LLC?

Goldpoint Clinical Research, LLC has a Crixeo Trust Score of 80/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Goldpoint Clinical Research, LLC conducted?

Goldpoint Clinical Research, LLC has 19 clinical trials on record. Their work covers Binge Eating Disorder, Smoking Cessation, ADHD.

Is Goldpoint Clinical Research, LLC accredited by Crixeo Health?

Yes — Goldpoint Clinical Research, LLC holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Goldpoint Clinical Research, LLC?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.